Loss of PIK3CA allows &lt;i&gt;in vitro&lt;/i&gt; growth but not &lt;i&gt;in vivo&lt;/i&gt; progression of KRAS mutant lung adenocarcinoma in a syngeneic orthotopic implantation model. This evidence concerns the gene KRAS and lung adenocarcinoma.